Adjuvant antitumor treatment
Research indicates that utilizing hyperbaric oxygen therapy (HBOT) in combination with radiotherapy or chemotherapy can significantly reduce mortality and relapse rates. HBOT aids cancer treatment by enhancing blood flow to tumors, inhibiting the growth of cancer cells (particularly hypoxic cancer cells, which are low in oxygen), and boosting the effectiveness of standard therapies.
Additionally, HBOT can help mitigate the side effects of cancer treatment, such as nausea, vomiting, and fatigue.
Click the links below to read the case studies below
HBOT Breast Cancer Study: https://pubmed.ncbi.nlm.nih.gov/34279734/
Managing end-case breast cancer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819722/